Scholarlink

Background <p>Epstein–Barr virus infection is common. However, to our knowledge, it has never been reported to cause synchronous acute acalculous cholecystitis and acute pancreatitis alongside hepatitis. This case highly suggests the potential for novel multiorgan involvement.</p> Case presentation <p>A 32-year-old Asian male patient presented with high-grade fever, abdominal pain, and jaundice. Comprehensive diagnostic evaluation confirmed acute hepatitis, acute acalculous cholecystitis, and acute pancreatitis. Histopathological examination of lymph node and liver biopsy specimens identified Epstein–Barr virus infection as the underlying cause of all three conditions. The patient was treated with dexamethasone at a dose of 5&#xa0;mg per day combined with acyclovir. Significant clinical improvement was observed, and the patient was subsequently discharged.</p> Conclusion <p>This is the first reported case of concurrent Epstein–Barr-virus-induced hepatitis, acute acalculous cholecystitis, and acute pancreatitis. The patient’s full recovery through nonsurgical management, including antiviral and antiinflammatory therapies, may provide valuable insights for future clinical practice.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Acute hepatitis with synchronous acalculous cholecystitis and pancreatitis in a patient with Epstein–Barr viral infection: a case report

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年1月22日

查看全文
  • He Wang,
  • Lan Hu,
  • Yuanyuan Zheng,
  • XinYan Zhao,
  • Jigang Yang,
  • Chao Wang,
  • Wenjie Qi

摘要

Background

Epstein–Barr virus infection is common. However, to our knowledge, it has never been reported to cause synchronous acute acalculous cholecystitis and acute pancreatitis alongside hepatitis. This case highly suggests the potential for novel multiorgan involvement.

Case presentation

A 32-year-old Asian male patient presented with high-grade fever, abdominal pain, and jaundice. Comprehensive diagnostic evaluation confirmed acute hepatitis, acute acalculous cholecystitis, and acute pancreatitis. Histopathological examination of lymph node and liver biopsy specimens identified Epstein–Barr virus infection as the underlying cause of all three conditions. The patient was treated with dexamethasone at a dose of 5 mg per day combined with acyclovir. Significant clinical improvement was observed, and the patient was subsequently discharged.

Conclusion

This is the first reported case of concurrent Epstein–Barr-virus-induced hepatitis, acute acalculous cholecystitis, and acute pancreatitis. The patient’s full recovery through nonsurgical management, including antiviral and antiinflammatory therapies, may provide valuable insights for future clinical practice.